Protagonist Therapeutics (PTGX) PT Raised to $112 at Citizens: 2 Approvals This Year
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $112.00 (from $102.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
